All ILMN Content

Illumina, Inc (ILMN) Illumina and Labcorp expand collaboration to broaden access to precision oncology testing

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

March 18, 20261 min read

Illumina, Inc (ILMN) Illumina advances preventive genomics through strategic consortium with Veritas Genetics

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

March 16, 20261 min read

Illumina, Inc (ILMN) Alliance For Genomic Discovery Expands With Regeneron Genetics Center Membership And New Proteomics Data Offering

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

March 5, 20261 min read

Illumina, Inc (ILMN) Illumia Unveils New Brand Identity at Momentum Conference, Announces 2026 Distinction Award Winners

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

March 4, 20261 min read

Illumina, Inc (ILMN) Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

February 27, 20261 min read

Illumina, Inc (ILMN) Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

February 25, 20261 min read

Illumina, Inc (ILMN) Illumina launches TruPath Genome, setting a new standard in genomic insight

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

February 24, 20261 min read

Illumina, Inc (ILMN) Illumina Unveils Roadmap Of Groundbreaking Novaseq X Advancements In Data Quality, Output, Speed, And Flexibility

Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release

February 23, 20261 min read

Illumina, Inc (ILMN) Q4 2025 Earnings Call

Illumina, Inc (NASDAQ: ILMN) Q3 2025 Earnings Conference

February 17, 20261 min read

Illumina, Inc (ILMN) Q4 2025 Earnings Call

Illumina, Inc (NASDAQ: ILMN) Q3 2025 Earnings Conference

February 17, 20261 min read